市场调查报告书
商品编码
1576653
笔针市场:类型(标准、安全)、针长、用途(一次性、可重复使用)、应用(胰岛素、生长激素、GLP-1)、分销管道(医院药房、零售、线上)、使用环境(家庭医疗)护理、医院)- 2031 年世界预测Pen Needles Market by Type (Standard, Safety), Needle Length, Usability (Disposable, Reuse), Application (Insulin, Growth Hormone, GLP-1), Distribution Channel (Hospital Pharmacy, Retail, Online), Setting (Home Care, Hospital) - Global Forecast to 2031 |
到 2031 年,笔用针头市场预计将达到 128.8 亿美元,2024 年至 2031 年复合年增长率为 9.9%。
经过广泛的二次和初步研究以及对市场情景的详细分析,本报告对关键行业推动因素、阻碍因素、课题和机会进行了分析。这种增长是由于糖尿病盛行率上升、自我用药需求增加、技术进步以及医疗保健成本增加所致。然而,对针刺伤的担忧限制了该市场的成长。
此外,人们对笔式针头的偏好超过了小瓶和注射器、新兴市场、有利的报销方案以及笔式註射器中人工智慧的引入,预计将为在该市场运营的公司提供成长机会。然而,笔针的重复使用、新兴国家获得医疗保健的机会有限以及缺乏正确使用笔针的意识是影响市场成长的主要课题。
(註:预定提供上位5公司的SWOT分析)
Pen Needles Market by Type (Standard, Safety), Needle Length, Usability (Disposable, Reuse), Application (Insulin, Growth Hormone, GLP-1), Distribution Channel (Hospital Pharmacy, Retail, Online), Setting (Home Care, Hospital)-Global Forecast to 2031
The pen needles market is projected to reach $12.88 billion by 2031 at a CAGR of 9.9% from 2024 to 2031.
Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. This growth is due to the rising prevalence of diabetes, growing demand for self-administration of drugs, advancements in technology, and rising healthcare expenditure. However, the needlestick injury concerns restrain the growth of this market.
Furthermore, the rising preference for pen needles over vials and syringes, emerging economies, favorable reimbursement scenarios, and implementation of AI in pen injectors are expected to generate growth opportunities for the players operating in this market. However, the reuse of pen needles, limited access to healthcare in developing nations, and lack of awareness about proper pen needle usage are major challenges impacting market growth.
The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over four years (2021-2024). The key players operating in the pen needles market are Becton, Dickinson and Company (U.S.), Novo Nordisk A/S (Denmark), Ypsomed AG (Switzerland), Owen Mumford Limited (U.K.), B. Braun Melsungen AG (Germany), Terumo Group (Japan), Allison Medical, Inc. (U.S.), Cardinal Health, Inc. (U.S.), UltiMed, Inc. (U.S.), Hindustan Syringes & Medical Devices Ltd (India), and Nanchang YiLi Medical Instrument Co., LTD (China).
Among all the types studied in this report, in 2024, the safety pen needles segment is expected to account for the largest share of the pen needles market. This segment's large share is driven by the benefits offered by safety pen needles, such as reducing the risk of needlestick injuries. Moreover, companies in the pen needles market are actively enhancing their product portfolios through the introduction of new products and obtaining regulatory approvals.
Among all the needle lengths studied in this report, in 2024, the 4 mm segment is expected to account for the larger share of the pen needles market. 4 mm needles have gained popularity as they reduce discomfort and pain associated with insulin injections. Patients find them less uncomfortable than longer needles, which improves adherence to insulin treatment. Therefore, patients who require regular injections often prefer shorter needles, contributing to the significant market share of this segment.
Among all the usabilities studied in this report, in 2024, the single-use/disposable segment is expected to account for the largest share of the pen needles market. Insulin pen needles are intended for single use only, offering several advantages over traditional syringes. Single-use pen needles provide improved dosing accuracy, ease of use, and reduced pain during injections. Additionally, they help to minimize the risk of infections due to their pre-sterilized nature, eliminating the need for cleaning or sterilization before each use, thereby contributing to the increased adoption of single-use/disposable pen needles.
Among all the applications studied in this report, in 2024, the insulin therapy segment is expected to account for the largest share of the pen needles market. This segment's large market share can be attributed to the rising prevalence of diabetes and the increasing awareness among diabetic patients about self-administration of insulin therapy. Furthermore, recent advancements in insulin therapy, such as ultra-long-acting basal insulin and ultra-rapid-acting insulin therapies, provide greater flexibility in the timing of dosing.
Among all the distribution channels studied in this report, in 2024, the retail pharmacies segment is expected to account for the largest share of the pen needles market. This segment's large market share can be attributed to the increasing consumer demand for pen needles and the opportunity for customers to inspect the product before making a purchase.
Among all the end users studied in this report, in 2024, the home care segment is expected to account for the largest share of the pen needles market. This segment's large market share is driven by several factors, including the growing preference among patients for self-administration of medications, technological advancements in pen needles, and the rising number of diabetes cases worldwide.
An in-depth analysis of the geographical scenario of the pen needles market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2024, North America is expected to account for the largest share of the pen needles market. In the region in 2024, the U.S. is expected to account for the largest share of the pen needles market in North America. The large share of this regional market is attributed to the presence of major pen needles companies, such as Becton, Dickinson and Company (U.S.) and Cardinal Health, Inc. (U.S.), the high adoption of pen needles devices in home care, and technological advancements in pen needles in the region.
Pen Needles Market Assessment-by Type
Pen Needles Market Assessment-by Needle Length
Pen Needles Market Assessment-by Usability
Pen Needles Market Assessment-by Application
Note: Other Applications include Osteoporosis, psoriasis, multiple sclerosis, and rheumatoid arthritis.
Pen Needles Market Assessment-by Distribution Channel
Pen Needles Market Assessment-by Healthcare Setting
Note: Other Healthcare Settings include nursing care centers, long-term care settings, and ambulatory care centers.
Pen Needles Market Assessment-by Geography
(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)